Maze Therapeutics Appoints New Chief Financial Officer
Maze Therapeutics has appointed Misbah Tahir as chief financial officer, adding a capital markets veteran ahead of a dense...
eClinical Tech News
Nobel Laureate Dr. Ardem Patapoutian Joins Stratus Board
Stratus Therapeutics has added Nobel laureate Ardem Patapoutian to its Scientific Advisory Board as it advances ST-101, an allogeneic,...
Rapafusyn Closes $44M Series A for Molecular Glue Platform
Rapafusyn Pharmaceuticals has closed an oversubscribed Series A round totaling $44 million, adding BioTrack Capital and Yonjin Capital to...
Rybrevant Combo Resets Survival in EGFR Lung Cancer
Johnson & Johnson’s amivantamab plus lazertinib delivered a statistically significant overall survival advantage over osimertinib monotherapy in first-line EGFR-mutated...
Hinge Bio Expands Leadership for Gem-Dimer Development
Hinge Bio has expanded its leadership bench and unveiled peer‑reviewed preclinical data for HB2198, a dual‑Fc, anti‑CD19/CD20 bispecific antibody...
Mosliciguat Gains Orphan Drug Designation in Japan for PH-ILD
Japan’s Ministry of Health, Labour and Welfare has granted orphan drug designation to mosliciguat, Pulmovant’s once-daily, inhaled soluble guanylate...
Radiance Biopharma Inks Exclusive ‘First in Class’ ADC Deal
Radiance Biopharma has secured an exclusive ex-China license to develop and commercialize RB-601 (KY-0301), a bispecific nanobody antibody-drug conjugate...
Arcutis’ Zoryve: A Promising New Hope for Kids’ Psoriasis
Arcutis has submitted a supplemental new drug application to the FDA seeking to expand Zoryve (roflumilast) cream 0.3% for...
Eisai Submits New Leqembi Subcutaneous Dose for Alzheimer’s
Eisai has begun a rolling FDA submission for a supplemental BLA to add a weekly, at-home initiation regimen for...
Cormedix Completes Melinta Acquisition, Surging Guidance
CorMedix has closed its acquisition of Melinta Therapeutics for $300 million upfront, adding seven marketed assets and a hospital-focused...